GLOBAL BLOOD THERAPEUTICS IN GBT
COM · Common Stock · CUSIP 37890U108 · ISIN US37890U1088
2
institutional holders
-244 vs Q3 2022
622
shares reported held*
$42.1kreported value*
0 new
0 added
1 reduced
237 sold out
net sold ≈ $4.7bn (-68.9m shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $67.63.
Trends to Q4 2022
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 246 |
| Q4 2022 | 2 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
CallsPuts
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q3 2022 | $145.1m | $86.1m | 0.59 |
| Q4 2022 | $0 | $0 | — |
Biggest buyers
| None |
Biggest sellers
| VANGUARD GROUP INC | Sold out | -6.3m |
| BlackRock Inc. | Sold out | -4.7m |
| BAKER BROS. ADVISORS LP | Sold out | -3.7m |
| Pentwater Capital Management LP | Sold out | -3.2m |
| STATE STREET CORP | Sold out | -2.4m |
| PERCEPTIVE ADVISORS LLC | Sold out | -2.3m |
| JPMORGAN CHASE & CO | Sold out | -2.3m |
| FIL Ltd | Sold out | -2.3m |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | Sold out | -2.2m |
| JANUS HENDERSON GROUP PLC | Sold out | -2.2m |
Holders, Q4 2022
| Manager | Shares | Change |
|---|---|---|
| Blue Trust, Inc. 0.00% of their portfolio | 621 $42.0k | Unchanged |
| HUNTINGTON NATIONAL BANK 0.00% of their portfolio | 1 $68 | Reduced -223 |